(Q62128613)

English

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell t

scientific article published on 21 July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

positron emission tomography

1 reference

based on heuristic

inferred from title

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Paolo Corradini

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

6

object named as

Fabio Ciceri

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Roberto Crocchiolo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Francesca Patriarca

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Stefania Bramanti

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Niccolo Frungillo

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Raffaella Milani

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Flavio Crippa

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Federico Fallanca

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Emanuela Englaro

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

116

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5001-5011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Flexible regression models with cubic splines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25357

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25357

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20665491%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q62128613&oldid=1567899449"